FDA Approves Wegovy for Liver Disease Affecting Millions of Americans
The Food and Drug Administration has granted accelerated approval for Wegovy, a widely prescribed weight-loss drug, to treat adults with metabolic-associated steatohepatitis (MASH – formerly referred to as NASH), a serious liver disease affecting nearly 15 million Americans – and even more people worldwide. The decision marks the second therapy approved by the FDA for … Read more